Comparison between contrast enhanced spectral mammography BIRADS and KASIER scoring systems in characterization of breast lesions

Breast cancer remains a major global health challenge, affecting millions worldwide and standing as the leading cause of cancer-related deaths among women. Over the past 40 years, its incidence has steadily risen, with an annual increase of about 0.5%. Addressing this issue requires advanced diagnostic tools for accurate and timely detection. One such innovation is contrast-enhanced spectral mammography, which produces four easily interpretable images with sensitivity comparable to magnetic resonance imaging (MRI). CESM is also more cost-effective and less time-consuming, making it a valuable alternative for assessing breast lesions.This article evaluates findings from various studies comparing two scoring systems used in contrast enhanced spectral mammography: The Breast Imaging Reporting and Data System (BI-RADS) and the Kaiser Score. These systems aim to standardize lesion assessment and improve diagnostic accuracy. The review highlights the strengths and limitations of each approach, particularly in differentiating benign from malignant lesions.In conclusion, the Kaiser Score demonstrates superior performance in evaluating suspicious borderline breast lesions, potentially reducing unnecessary biopsies. Its ability to provide precise risk stratification makes it a valuable tool in clinical practice, enhancing patient management and minimizing invasive procedures. This underscores the importance of integrating advanced scoring systems like the Kaiser Score into breast imaging protocols for improved diagnostic outcomes.